Bausch Health Companies Inc. (FRA:BVF)

Germany flag Germany · Delayed Price · Currency is EUR
5.60
-0.19 (-3.33%)
At close: Nov 13, 2025
-35.32%
Market Cap 2.34B
Revenue (ttm) 8.55B
Net Income (ttm) 308.53M
Shares Out n/a
EPS (ttm) 0.82
PE Ratio 7.60
Forward PE 1.78
Dividend n/a
Ex-Dividend Date n/a
Volume 400
Average Volume 583
Open 5.71
Previous Close 5.79
Day's Range 5.70 - 5.71
52-Week Range 3.99 - 7.94
Beta n/a
RSI 45.89
Earnings Date Feb 19, 2026

About Bausch Health Companies

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The Intern... [Read more]

Industry Pharmaceutical Preparations
CEO Thomas Appio
Employees 20,700
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol BVF
Full Company Profile

Financial Performance

In 2024, Bausch Health Companies's revenue was $9.63 billion, an increase of 9.91% compared to the previous year's $8.76 billion. Losses were -$46.00 million, -92.23% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.